Imagion Biosystems Ltd has released a press release.
Imagion MagSense Breast Cancer Program Phase 2 Trial Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Imagion Biosystems Ltd. on 6ix
Story so far
Earlier from Imagion Biosystems
- Imagion Receive Positive FDA Feedback for HER2 Phase 2 Trial
- Appendix 4C and Quarterly Activities Report - March 2025
- Appendix 4E and 2024 Financial Report
- Imagion Initiates Manufacturing of Drug for Phase 2 Study
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from Imagion Biosystems
- Appendix 4C and Quarterly Activities Report - June 2025
- Trading Halt
- IBX Secures Firm Commitments for A$3.5m Capital Raising
- Appendix 4D and Half-yearly Financial Report
- Ph2 Manufacturing & Imaging Optimisation Activities Commence
Follow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems